Malignant progression of rat Nb2 lymphoma cells: Chromosomal alterations and metastatic properties

Cancer Genetics and Cytogenetics

Volumn 110, Issue 2, 1999, Pages 115-123

  Too, Catherine K L ^a   Lee, Christine ^a   Sangster, Shirley M ^a   Gout, Peter W ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CHROMOSOME ABERRATION; CYTOGENETICS; KARYOTYPE; LYMPHOMA; LYMPHOMA CELL; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; T CELL LYMPHOMA;

ANIMALS; CARCINOGENICITY TESTS; CELL DIVISION; CHROMOSOME ABERRATIONS; CULTURE MEDIA; KARYOTYPING; LYMPHOMA, T-CELL; MALE; NEOPLASM METASTASIS; PROLACTIN; RATS; TRISOMY; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033561106     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00191-5     Document Type: Article

References (39)

1. Nowell P.C. Mechanisms of tumor progression. Cancer Res. 46:1986;2203-2207.
2. Nicholson G.L. Tumor cell instability, diversification, and progression to the metastatic phenotype. from oncogene to oncofetal expression Cancer Res. 47:1987;1473-1487.
3. Yeatman T.J., Nicolson G.L. Molecular basis of tumor progression. mechanisms of organ-specific tumor metastasis Semin Surg Oncol. 9:1993;256-263.
4. El-Ashry D., Lipmann M.E. Molecular biology of breast carcinoma. World J Surg. 18:1994;12-20.
5. Gout P.W., Horsman D.E., Fox K., De Jong G., Ma S., Bruchovsky N. The rat Nb2 lymphoma. a novel model for tumor progression Anticancer Res. 14:1994;2485-2492.
6. Gout P.W. Transient requirement for prolactin as a growth initiator following treatment of autonomous Nb2 node rat lymphoma cell cultures with butyrate. Cancer Res. 47:1987;1751-1755.
7. Horsman D.E., Masui S., Gout P.W. Karyotypic changes associated with loss of prolactin dependency of rat Nb2 node lymphoma cell cultures. Cancer Res. 51:1991;282-287.
8. Gout P.W., Beer C.T., Noble R.L. Prolactin-stimulated growth of cell cultures established from malignant Nb2 rat lymphomas. Cancer Res. 40:1980;2433-2436.
9. Shiu R.P.C., Elsholtz H.P., Tanaka T., Friesen H.G., Gout P.W., Beer C.T., Noble R.L. Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology. 113:1983;159-165.
10. Gilks C.B., Porter S.D., Barker C., Tsichlis P.N., Gout P.W. Prolactin (PRL)-dependent expression of a zinc finger protein-encoding gene. Gfi-1, in Nb2 lymphoma cells. constitutive expression in autonomous sublines Endocrinology. 136:1995;1805-1808.
11. Buckley A.R., Krumenacker J.S., Buckley D.J., Leff M.A., Magnuson N.S., Reid J.C., Miyashita T., de Jong G., Gout P.W. Butyrate-induced reversal of dexamethasone resistance in autonomous rat Nb2 lymphoma cells. Apoptosis. 2:1997;518-528.
12. Gout P.W., Kang Y.J., Buckley D.J., Bruchovsky N., Buckley A.R. Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia. 11:1997;1329-1337.
13. Gertler A., Friesen H.G. Human growth hormone-stimulated mitogenesis of Nb2 node lymphoma is not mediated by an immediate acceleration of phosphoinositide metabolism. Mol Cell Endocrinol. 48:1986;221-228.
14. Walker A., Croze F., Friesen H.G. A serum-free medium for culturing lactogen dependent and autonomous Nb2 node lymphoma cells. Endocrinology. 120:1987;2389-2397.
15. Gertler A., Walker A., Friesen H.G. Enhancement of human growth hormone-stimulated mitogenesis of Nb2 node lymphoma cells by 12-0-tetradecanoyl-phorbol-13-acetate. Endocrinology. 116:1985;1636-1644.
16. Ashkenazi A., Cohen R., Gertler A. Characterization of lactogen receptors in lactogenic hormone-dependent and independent Nb2 lymphoma cell lines. FEBS Lett. 210:1987;51-55.
17. Too C.K.L., Murphy P.R., Friesen H.G. The role of G-proteins in the mitogenesis of rat lactogen-dependent and lactogen-independent Nb2 lymphoma cells. Endocrinology. 126:1990;1368-1373.
18. Clevenger C.V., Torigoe T., Reed J.C. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated Raf-1 kinase in a T-cell line. J Biol Chem. 269:1994;5559-5565.
19. O'Neal K.D., Yu-Lee L.-Y. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-. 1(and cell proliferation. J Biol Chem 269):1994;26076-26082.
20. Too C.K.L. Differential expression of elongation factor-2, alpha4 phosphoprotein and Cdc5-like protein in prolactin-dependent/independent rat lymphoid cells. Mol Cell Endocrinol. 131:1997;221-232.
21. nrb-related mRNA in rat lymphoma cells. Mol Cell Endocrinol. 137:1997;187-195.
22. Paton G.R., Jacobs J.P., Perkins F.T. Chromosome changes in human diploid-cell cultures infected with Mycoplasma. Nature. 207:1965;43-45.
23. Seabright M (1971): A rapid banding technique for human chromosomes. Lancet ii:971-972.
24. Levan G. Nomenclature for G-bands in rat chromosomes. Hereditas. 77:1974;37-52.
25. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
26. Belge G., Thode B., Rippe V., Bartnitzke S., Bullerdiek J. A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet. 94:1994;198-202.
27. Dal Cin P., Aly S., Delabie J., Ceuppens J.L., van Gool S., van Damme B., Baert L., van Poppel H., van den Berghe H. Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc Natl Acad Sci USA. 89:1992;9744-9748.
28. Yeung R.S., Bell D.W., Testa J.R., Mayol X., Baldi A., Grana X., Klinga-Levan K., Knudson A.G., Giordano A. The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene. 8:1993;3465-3468.
29. Szpirer C., Tissir F., Riviere M., Levan G., Szpirer J. Assignment of rat Jun family genes to chromosome 19, chromosome 5q31-33 (Jun), and chromosome 16 (Jund). Mamm Genome. 5:1994;361-364.
30. Szpirer C., Riviere M., Szpirer J., Levan G., Jaspers M., Vekemans S., Cassiman J.J. Assignment of three rat integrin genes to chromosome 19 (ITGB1), chromosome 3 (ITGA4), and chromosome 7 (ITGA5). Mamm Genome. 3:1992;685-688.
31. Weimar I.S., de Jong D., Muller E.J., Nakamura T., van Gorp J.M., de Gast G.C., Gerritsen W.R. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood. 89:1997;990-1000.
32. O'Brien SJ (1990): From: Genetic Maps. Locus Maps of Complex Genomes, 5th Ed. Nonhuman Vertebrates, Book 4. Cold Spring Harbor Laboratory Press 4.80-4.88.
33. Starkey C.R., Levy L.S. Identification of differentially expressed genes in T-lymphoid malignancies in an animal model system. Int J Cancer. 62:1995;325-331.
34. Horseman N.D., Yu-Lee L.-Y. Transcriptional regulation by the helix bundle peptide hormones. growth hormone, prolactin, and hematopoietic cytokines Endocr Rev. 15:1994;627-649.
35. Sumegi J., Spira J., Bazin H., Szpirer J., Levan G., Klein G. Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6;7) chromosomal translocation. Nature. 306:1983;497-498.
36. Szpirer J., Szpirer C., Riviere M., Levan G., Marynen P., Cassiman J.J., Wiese R., DeLuca H.F. The Sp1 transcription factor gene (SP1) and 1, 25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics. 11:1991;168-173.
37. Tsichlis P.N., Lohse M.A., Szpirer C., Szpirer J., Levan G. Cellular DNA regions involved in the induction of rat thymic lymphomas (Mlvi-1, Mlvi-2, Mlvi-3 and c-myc) represent independent loci as determined by their chromosomal map location in the rat. J Virol. 56:1985;938-942.
38. Fleming W.H., Murphy P.R., Murphy L.J., Hatton T.W., Matusik R.J., Friesen H.G. Human growth hormone induces and maintains c-myc gene expression in Nb2 lymphoma cells. Endocrinology. 117:1985;2547-2549.
39. Too C.K.L. Induction of Sp1 activity by prolactin and interleukin-1 in Nb2 T cells. differential association of Sp1-DNA complexes with Stats Mol Cell Endocrinol. 129:1997;7-16.